Huntington National Bank’s Albireo Pharma Inc ALBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $44 | Hold |
1
| – | – | ﹤0.01% | 2991 |
|
|
2025
Q4 | $44 | Hold |
1
| – | – | ﹤0.01% | 2910 |
|
|
2025
Q3 | $744 | Hold |
1
| – | – | ﹤0.01% | 2335 |
|
|
2025
Q2 | $744 | Hold |
1
| – | – | ﹤0.01% | 2384 |
|
|
2025
Q1 | $744 | Hold |
1
| – | – | ﹤0.01% | 2414 |
|
|
2024
Q4 | $744 | Hold |
1
| – | – | ﹤0.01% | 2436 |
|
|
2024
Q3 | $744 | Hold |
1
| – | – | ﹤0.01% | 2435 |
|
|
2024
Q2 | $744 | Hold |
1
| – | – | ﹤0.01% | 2362 |
|
|
2024
Q1 | $744 | Hold |
1
| – | – | ﹤0.01% | 2323 |
|
|
2023
Q4 | $744 | Hold |
1
| – | – | ﹤0.01% | 2263 |
|
|
2023
Q3 | $744 | Hold |
1
| – | – | ﹤0.01% | 2247 |
|
|
2023
Q2 | $756 | Hold |
1
| – | – | ﹤0.01% | 2204 |
|
|
2023
Q1 | $799 | Sell |
1
-804
| -100% | -$33.7K | ﹤0.01% | 2052 |
|
|
2022
Q4 | $17.4K | Sell |
805
-80
| -9% | -$1.69K | ﹤0.01% | 1336 |
|
|
2022
Q3 | $17K | Buy |
885
+206
| +30% | +$4.26K | ﹤0.01% | 1361 |
|
|
2022
Q2 | $13K | Buy |
679
+574
| +547% | +$15.1K | ﹤0.01% | 1503 |
|
|
2022
Q1 | $3K | Sell |
105
-2
| -2% | -$59 | ﹤0.01% | 1875 |
|
|
2021
Q4 | $2K | Buy |
+107
| New | +$2.85K | ﹤0.01% | 1924 |
|
Huntington National Bank's ALBO Position: Q1 2026 in Review
Huntington National Bank held its Albireo Pharma Inc (ALBO) position steady in Q1 2026 at 1 share worth $44. The position accounts for ﹤0.01% of the portfolio, ranked #2991.
Huntington National Bank first reported a position in ALBO in Q4 2021 and has held it in 18 quarters since. The position peaked at $17.4K in Q4 2022. 1 fund tracked by Wall St. Rank holds ALBO as of Q1 2026.
- Huntington National Bank held 1 share of Albireo Pharma Inc worth $44 as of Q1 2026.
- Huntington National Bank left its Albireo Pharma Inc share count unchanged in Q1 2026.
- Albireo Pharma Inc made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #2991 holding.
- Huntington National Bank first reported a position in Albireo Pharma Inc in Q4 2021 and has held it in 18 quarters since.
- Huntington National Bank's Albireo Pharma Inc position peaked at $17.4K in Q4 2022.
- 1 fund tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2026.
Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.